Caricamento...
Clinical validity of detecting circulating tumor cells by AdnaTest assay compared to direct detection of tumor mRNA in stabilized whole blood, as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients
Circulating tumor cell (CTC) number measured with the CellSearch(®) assay is prognostic for survival in metastatic castration-resistant prostate cancer (mCRPC) pre- and post-therapy. Using a standard operating protocol for sample collection, processing, and analysis, we compared detection rates of C...
Salvato in:
| Pubblicato in: | Cancer J |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5108569/ https://ncbi.nlm.nih.gov/pubmed/27749322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000220 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|